PTGXProtagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric p…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
 Silence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccines Some analysts believe Silence’s polycythemia vera drug could be superior to a closely watched Takeda medicine. Elsewhere, the FDA spurned a radiopharmaceutical and AbCellera shares climbed to levels not seen since 2023. | ||
Silence Therapeutics' Divesiran Data Support Best-in-Class Potential, Morgan Stanley Says Silence Therapeutics' (SLN) Phase 2 results for divesiran in polycythemia vera showed stronger activ | MMT Newswires | |
 4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026 PTGX, ALMS, ORKA and VNDA offer diverse psoriasis opportunities, spanning approved therapies, late-stage candidates and earlier-stage programs. | ||
 Surging Earnings Estimates Signal Upside for Protagonist Therapeutics (PTGX) Stock Protagonist Therapeutics (PTGX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. | ||
 Protagonist Therapeutics (PTGX) Beats Q2 Earnings Estimates Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of +8.53% and -3.12%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 Alnylam Pharmaceuticals (ALNY) Misses Q2 Earnings and Revenue Estimates Alnylam (ALNY) delivered earnings and revenue surprises of -10.24% and -2.09%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 Best Momentum Stocks to Buy for July 13th SNDK, PTGX and LION made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 13th, 2026. | ||
 New Strong Buy Stocks for July 13th FOX, LION, EDRY, PTGX and SPH have been added to the Zacks Rank #1 (Strong Buy) List on July 13th, 2026. | ||